S&P 500 · Health Care · USD · FY end 2025-12-31
Dexcom (DXCM) financials — revenue, earnings, margins, balance sheet, cash flow and dividends. 10-year history sourced from SEC filings.
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| FY2025 | 4.66B | 836.30M | 2.09 | 1.08B |
| FY2024 | 4.03B | 576.20M | 1.42 | 630.70M |
| FY2023 | 3.62B | 541.50M | 1.30 | 511.90M |
| FY2022 | 2.91B | 341.20M | 0.82 | 304.70M |
| FY2021 | 2.45B | 154.70M | 1.55 | 53.30M |